Antagonistic effects of a 50 Hz magnetic field and melatonin in the proliferation and differentiation of hepatocarcinoma cells

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1502-1516

  Cid, María Antonia ^a   Úbeda, Alejandro ^a   Hernández Bule, María Luisa ^a   Martínez, María Antonia ^a   Trillo, María Ángeles ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Albumin; Alpha fetoprotein; Differentiation; ELF; HepG2; Melatonin; Power frequency; Proliferation

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; BROXURIDINE; MELATONIN; TRYPAN BLUE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; EXTREMELY LOW FREQUENCY MAGNETIC FIELD; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; MAGNETIC FIELD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE;

EID: 84870749859     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343338     Document Type: Article

References (87)

1. Ahlbom A, Cardis E, Green A, Linet M, Savitz D, Swerdlow A: Review of the epidemiologic literature on EMF and Health. Environ Health Perspect 2001;109:911-933. (Pubitemid 34055930)
2. Li P, McLaughlin J, Infante-Rivard C: Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer in the offspring. Cancer Causes Control 2009;20:945-955.
3. Teepen JC, Van Dijck JA: Impact of high electromagnetic field levels on childhood leukaemia incidence. Int J Cancer 2012;131:769-778.
4. Lange S, Viergutz T, Simkó M: Modifications in cell cycle kinetics and in expression of G1 phase-regulating proteins in human amniotic cells after exposure to electromagnetic fields and ionizing radiation. Cell Prolif 2004;37:337-349. (Pubitemid 39281184)
5. Simkó M: Cell type specific redox status is responsible for diverse electromagnetic field effects. Curr Med Chem 2007;14:1141-1152. (Pubitemid 46672632)
6. Basile A, Zeppa R, Pasquino N, Arra C, Ammirante M, Festa M, Barbieri A, Giudice A, Pascale M, Turco MC, Rosati A: Exposure to 50 Hz electromagnetic field raises the levels of the anti-apoptotic protein BAG3 in melanoma cells. J Cell Physiol 2011;226:2901-2907.
7. Negishi T, Imai S, Shibuya K, Nishimura I, Shigemitsu T: Lack of promotion effects of 50 Hz magnetic fields on 7, 12-dimethylbenz (a) anthracene-induced malignant lymphoma/lymphatic leukemia in mice. Bioelectromagnetics 2008;29:29-38.
8. Ruiz-Gómez MJ, Merino-Moyano MD, Cebrián-Martín MG, Prieto-Barcia MI, Martínez-Morillo M: No effect of 50 Hz 2.45 mT magnetic field on the potency of cisplatin, mitomycin C, and methotrexate in S. cerevisiae. Electromagn Biol Med 2008;27:289-297.
9. Chung MK, Yu WJ, Kim YB, Myung SH: Lack of a co-promotion effect of 60 Hz circularly polarized magnetic fields on spontaneous development of lymphoma in AKR mice. Bioelectromagnetics 2010;31:130-139.
10. Pérez-Castejón C, Pérez-Bruzón RN, Llorente M, Pes N, Lacasa C, Figols T, Lahoz M, Maestú C, Vera-Gil A, Del Moral A, Azanza MJ: Exposure to ELF-pulse modulated X band microwaves increases in vitro human astrocytoma cell proliferation. Histol Histopathol 2009;24:1551-1561.
11. Santini MT, Rainaldi G, Indovina PL: Cellular effects of extremely low frequency (ELF) electromagnetic fields. Int J Radiat Biol 2009;85:294-313.
12. Trillo MA, Martínez MA, Cid MA, Leal J, Úbeda A: Influence of a 50 Hz magnetic field and of all-trans-retinol on the proliferation of human cancer cell lines. Int J Oncol 2012;40:1405-1413.
13. Juutilainen J: Do electromagnetic fields enhance the effects of environmental carcinogens? Radiat Prot Dosimetry 2008;132:228-231.
14. Yang Y, Jin X, Yan C, Tian Y, Tang J, Shen X: Case-only study of interactions between DNA repair genes (hMLH1, APEX1, MGMT, XRCC1 and XPD) and low-frequency electromagnetic fields in childhood acute leukemia. Leuk Lymphoma 2008;49:2344-2350.
15. Comba P, Fazzo L: Health effects of magnetic fields generated from power lines: new clues for an old puzzle. Ann Ist Super Sanita 2009;45:233-237.
16. Trillo MA, Martínez MA, Cid MA, Úbeda A: Retinoic acid inhibits the cytoproliferative response to weak, 50 Hz magnetic fields on neuroblastoma cells. Oncol Report (in press).
17. Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC: Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett 2002;2:S52-56.
18. Cui P, Yu M, Peng X, Dong L, Yang Z: Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression. J Pineal Res 2012;2:236-243.
19. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, Reiter RJ: Basic mechanisms involved in the anticancer effects of melatonin. Curr Med Chem 2010;17:4462-4481.
20. Sharman EH, Sharman KG, Bondy SC: Extended exposure to dietary melatonin reduces tumor number and size in aged male mice. Exp Gerontol 2011;46:18-22.
21. Cos S, Garcia-Bolado A, Sánchez-Barceló EJ: Direct antiproliferative effects of melatonin on two metastatic cell sublines of mouse melanoma (B16BL6 and PG19). Melanoma Res 2001;11:197-201. (Pubitemid 32385825)
22. Martín V, Herrera F, García-Santos G, Antolín I, Rodriguez-Blanco J, Medina M, Rodriguez C: Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells. J Pineal Res 2007;43:239-244. (Pubitemid 47353002)
23. Fan LL, Sun GP, Wei W, Wang ZG, Ge L, Fu WZ, Wang H: Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J Gastroenterol 2010;16:1473-1481.
24. Carbajo-Pescador S, García-Palomo A, Martín-Renedo J, Piva M, González-Gallego J, Mauriz JL: Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor. J Pineal Res 2011;51:463-471.
25. Jung-Hynes B, Schmit TL, Reagan-Shaw SR, Siddiqui IA, Mukhtar H, Ahmad N: Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res 2011;50:140-149.
26. Kannen V, Marini T, Zanette DL, Frajacomo FT, Silva GE, Silva WA Jr, Garcia SB: The melatonin action on stromal stem cells within pericryptal area in colon cancer model under constant light. Biochem Biophys Res Commun 2011;405:593-598.
27. Proietti S, Cucina A, D'Anselmi F, Dinicola S, Pasqualato A, Lisi E, Bizzarri M: Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res 2011;50:150-158.
28. Cos S, Fernández R, Güézmes A, Sánchez- Barceló EJ: Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998;58:4383-4390. (Pubitemid 28450041)
29. Ortíz-López L, Morales-Mulia S, Ramírez- Rodríguez G, Benítez-King G. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 2009;46:15-21.
30. Sánchez-Hidalgo M, Guerrero JM, Villegas I, Packham G, De La Lastra CA: Melatonin, a natural programmed cell death inducer in cancer. Curr Med Chem 2012;19:3805-3821.
31. Úbeda A, Trillo MA, House DE, Blackman CF: Melatonin enhances junctional transfer in normal C3H/10T1/2 cells. Cancer Lett 1995;91:241-245.
32. Blackman CF, Andrews PW, Úbeda A, Wang X, House DE, Trillo MA, Pimentel ME: Physiological levels of melatonin enhance gap junction communication in primary cultures of mouse hepatocytes. Cell Biol Toxicol 2001;17:1-9. (Pubitemid 32624738)
33. Zaminy A, Kashani IR, Barbarestani M, Hedayatpour A, Mahmoudi R, Vardasbi S, Shokrgozar MA: Effects of melatonin on the proliferation and differentiation of rat adipose-derived stem cells. Indian J Plast Surg 2008;41:8-14.
34. Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, Jeong SJ, Park YG, Hoon Kim S: Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res 2011;51:187-194.
35. Zhang S, Zuo L, Gui S, Zhou Q, Wei W, Wang Y: Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol Biol Rep 2012;39:2843-2849.
36. Cutando A, López-Valverde A, Arias-Santiago S, De Vicente J, De Diego RG: Role of melatonin in cancer treatment. Anticancer Res 2012;32:2747-2753.
37. Stevens RG: Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987;125:556-561. (Pubitemid 17047129)
38. Vanderstraeten J, Verschaeve L, Burda H, Bouland C, De Brouwer C: Health effects of extremely lowfrequency magnetic fields: reconsidering the melatonin hypothesis in the light of current data on magnetoreception. J Appl Toxicol 2012; DOI: 10.1002/jat.2761.
39. Úbeda A, Trillo MA, House DE, Blackman CF: A 50 Hz magnetic field blocks melatonin-induced enhancement of junctional transfer in normal C3H/10T1/2 cells. Carcinogenesis 1995;16:2945-2949. (Pubitemid 26004189)
40. Úbeda A, Trillo MA, House DE, Blackman CF: Melatonin prevents magnetic-field-induced neurite outgrowth in a subline of pheochromocytoma cells, PC12D. Bioelectrochem Bioenerg 1996;39:77-81.
41. Chacón L: 50-Hz sinusoidal magnetic field effect on in vitro pineal n-acetyltransferase activity. Electro Magnetobiol 2000;19:339-343.
42. Jajte J, Zmyslony M: The role of melatonin in the molecular mechanism of weak, static and extremely low frequency (50 Hz) magnetic fields (ELF). Med Pr 2000;51:51-57.
43. Blackman CF, Benane SG, House DE: The influence of 1.2 microT, 60 Hz magnetic fields on melatonin-and tamoxifen-induced inhibition of MCF-7 cell growth. Bioelectromagnetics 2001;22:122-128. (Pubitemid 33612421)
44. Ishido M, Nitta H, Kabuto M: Magnetic fields (MF) of 50 Hz at 1.2 μT as well as 100 μT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells. Carcinogenesis 2001;22:1043-1048. (Pubitemid 32633602)
45. Girgert R, Hanf V, Emons G, Gründker C: Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields. Bioelectromagnetics 2010;31:237-245.
46. Hernández-Bule ML, Trillo MA, Cid MA, Leal J, Úbeda A: In vitro exposure to 0.57-MHz electric currents exerts cytostatic effects in HepG2 human hepatocarcinoma cells. Int J Oncol 2007;30:583-592.
47. Zha L, Fan L, Sun G, Wang H, Ma T, Zhong F, Wei W: Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. J Pineal Res 2012;52:322-331.
48. Cabrera R, Nelson DR: Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2010;15:461-476.
49. Cha CH, Saif MW, Yamane BH, Weber SM: Hepatocellular carcinoma: current management. Curr Probl Surg 2010;47:10-67.
50. Martínez MA, Úbeda A, Cid MA, Trillo MA: The Proliferative Response of NB69 Human Neuroblastoma Cells to a 50 Hz Magnetic Field is mediated by ERK1/2 Signaling. Cell Physiol Biochem 2012;29:675-686.
51. Tam CW, Mo CW, Yao KM, Shiu SY: Signaling mechanisms of melatonin in antiproliferation of hormonerefractory 22rv1 human prostate cancer cells: implications for prostate cancer chemoprevention. J Pineal Res 2007;42:191-202. (Pubitemid 46233066)
52. Winczyk K, Fuss-Chmielewska J, Lawnicka H, Pawlikowski M, Karasek M: Luzindole but not 4-phenyl-2-propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Neuro Endocrinol Lett 2009;30:657-662.
53. REFLEX-Project final report: Risk evaluation of potential environmental hazards from low energy electromagnetic field exposure using sensitive in vitro methods. Final Report 2004. Retrieved from: http://www.powerwatch.org.uk/pdfs/ 20041222-reflex.pdf. (Last accessed 23 July 2012).
54. Reiter RJ, Tan DX: What constitutes a physiological concentration of melatonin? J Pineal Res 2003;34:79-80. (Pubitemid 36140362)
55. Bubenik GA: Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol 2008;59:S33-51.
56. Stoimenov I, Helleday T: PCNA on the crossroad of cancer. Biochem Soc Trans 2009;37:605-613.
57. Darlington GJ, Kelly JH, Buffone GJ: Growth and hepatospecific gene expression of human hepatoma cells in a defined medium. In Vitro Cell Dev Biol 1987;23:349-354.
58. Li MS, Li PF, He SP, Du GG, Li G: The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J Gastroenterol 2002;8:469-475. (Pubitemid 34692744)
59. Vianale G, Reale M, Amerio P, Stefanachi M, Di Luzio S, Muraro R: Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production. Br J Dermatol 2008;158:1189-1196. (Pubitemid 351692868)
60. Wolf FI, Torsello A, Tedesco B, Fasanella S, Boninsegna A, D'Ascenzo M, Grassi C, Azzena GB, Cittadini A: 50-Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: possible involvement of a redox mechanism. Biochim Biophys Acta 2005;1743:120-129. (Pubitemid 40380612)
61. Sul AR, Park SN, Suh H: Effects of sinusoidal electromagnetic field on structure and function of different kinds of cell lines. Yonsei Med J 2006;47:852-861. (Pubitemid 46029645)
62. Ke XQ, Sun WJ, Lu DQ, Fu YT, Chiang H: 50-Hz magnetic field induces EGF-receptor clustering and activates RAS. Int J Radiat Biol 2008;84:413-420. (Pubitemid 351878840)
63. Zheng T, Yang W, Song T, Huo XL: Effects of low frequency pulsed magnetic field on the proliferation and differentiation of HepG2 cells. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2003;21:326-328.
64. Ross SM: Combined DC and ELF magnetic fields can alter cell proliferation. Bioelectromagnetics 1990;11:27-36. (Pubitemid 20295476)
65. Zhang X, Zhang J, Qu X, Wen J: Effects of different extremely low-frequency electromagnetic fields on osteoblasts. Electromagn Biol Med 2007;26:167-177. (Pubitemid 47460965)
66. McCreary CR, Dixon SJ, Fraher LJ, Carson JJ, Prato FS: Real-time measurement of cytosolic free calcium concentration in Jurkat cells during ELF magnetic field exposure and evaluation of the role of cell cycle. Bioelectromagnetics 2006;27:354-364. (Pubitemid 44015484)
67. Zhang X, Liu X, Pan L, Lee I: Magnetic fields at extremely low-frequency (50 Hz, 0.8 mT) can induce the uptake of intracellular calcium levels in osteoblasts. Biochem Biophys Res Commun 2010;396:662-666.
68. Jin M, Blank M, Goodman R: ERK1/2 phosphorylation, induced by electromagnetic fields, diminishes during neoplastic transformation. J Cell Biochem 2000;78:371-379. (Pubitemid 30491066)
69. Nie K, Henderson A: MAP kinase activation in cells exposed to a 60 Hz electromagnetic field. J Cell Biochem 2003;90:1197-1206. (Pubitemid 37485055)
70. Frahm J, Mattsson MO, Simkó M: Exposure to ELF magnetic fields modulate redox related protein expression in mouse macrophages. Toxicol Lett 2010;192:330-336.
71. International Commission on Non-Ionising Radiation Protection (ICNIRP): Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz). Health Phys 1998;74:494-522.
72. Di Nallo AM, Strigari L, Giliberti C, Bedini A, Palomba R, Benassi M: Monitoring of people and workers exposure to the electric, magnetic and electromagnetic fields in an Italian National Cancer Institute. J Exp Clin Cancer Res 2008;27:16.
73. Osseni RA, Rat P, Bogdan A, Warnet JM, Touitou Y: Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000;68:387-399. (Pubitemid 32011892)
74. McMillan CR, Sharma R, Ottenhof T, Niles LP: Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells. Neurosci Lett 2007;419:202-206. (Pubitemid 46755488)
75. Cucina A, Proietti S, D'Anselmi F, Coluccia P, Dinicola S, Frati L, Bizzarri M: Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J Pineal Res 2009;46:172-180.
76. Elattar TM, Virji AS: The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 2000;20:1733-1738. (Pubitemid 30628195)
77. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S: Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004;546:121-165. (Pubitemid 40103418)
78. Martín-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andrés O, González P, González-Gallego J: Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008;45:532-540.
79. Sánchez-Sánchez AM, Martín V, García-Santos G, Rodríguez-Blanco J, Casado-Zapico S, Suarez-Garnacho S, Antolín I, Rodriguez C: Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells. Free Radic Res 2011;45:1333-1341.
80. Liu J, Zhou H, Fan W, Dong W, Fu S, He H, Huang F: Melatonin influences proliferation and differentiation of rat dental papilla cells in vitro and dentine formation in vivo by altering mitochondrial activity. J Pineal Res 2012 DOI: 10.1111/jpi.12002.
81. Liburdy RP, Sloma TR, Sokolic R, Yaswen P: ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation. J Pineal Res 1993;14:89-97. (Pubitemid 23185237)
82. Harland JD, Liburdy RP: Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 1997;18:555-562. (Pubitemid 127476506)
83. Shah JP, Midkiff P, Brandt PC, Sisken BF: Growth and differentiation of PC6 cells: the effects of pulsed electromagnetic fields (PEMF). Bioelectromagnetics 2001;22:267-271. (Pubitemid 33608599)
84. Pirozzoli C, Marino C, Lovisolo GA, Laconi C, Mosiello L Negroni A: Effects of 50 Hz electromagnetic field exposure on apoptosis and differentiation in a neuroblastoma cell line. Bioelectromagnetics 2003;24:510-516. (Pubitemid 38622787)
85. Hevia D, Mayo JC, Quiros I, Gomez-Cordoves C, Sainz RM: Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC. Anal Bioanal Chem 2010;397:1235-1244.
86. Yan JJ, Shen F, Wang K, Wu MC: Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study. Hepatobiliary Pancreat Dis Int 2002;1:183-186. (Pubitemid 36748198)
87. Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G: Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003;35:12-15. (Pubitemid 36819165)